Prasanth Reddy
Overview
Explore the profile of Prasanth Reddy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
438
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Huang R, Li X, Haberberger J, Sokol E, Severson E, Duncan D, et al.
Oncologist
. 2020 Sep;
25(11):943-953.
PMID: 32869930
Background: We examined the current biomarker landscape in breast cancer when programmed death-ligand 1 (PD-L1) testing is integrated with comprehensive genomic profiling (CGP). Material And Methods: We analyzed data from...
12.
Madison R, Gupta S, Elamin Y, Lin D, Pal S, Necchi A, et al.
BJU Int
. 2020 Jan;
125(5):739-746.
PMID: 31985116
Objective: To review the genomic landscape of advanced urothelial carcinoma (UC) to assess the frequencies of EGFR and ERBB2 (HER2) alterations. Materials And Methods: Tumour specimens from 3753 patients with...
13.
Necchi A, Madison R, Raggi D, Jacob J, Bratslavsky G, Shapiro O, et al.
Eur Urol
. 2020 Jan;
77(4):548-556.
PMID: 31959546
Background: In patients with rare histologies of bladder cancer, including adenocarcinoma of the bladder (ACB) and squamous-cell carcinoma (SCC), there are limited standard therapy options, defining an unmet medical need....
14.
Klempner S, Fabrizio D, Bane S, Reinhart M, Peoples T, Ali S, et al.
Oncologist
. 2019 Oct;
25(1):e147-e159.
PMID: 31578273
Treatment with immune checkpoint inhibitors (ICPIs) extends survival in a proportion of patients across multiple cancers. Tumor mutational burden (TMB)-the number of somatic mutations per DNA megabase (Mb)-has emerged as...
15.
Necchi A, Bratslavsky G, Shapiro O, Elvin J, Vergilio J, Killian J, et al.
Eur Urol Focus
. 2019 Jun;
5(5):748-755.
PMID: 31147264
Background: Metastatic testicular sex cord stromal tumors of the testis (MSCSTs) comprise an extremely uncommon form of genitourinary malignancy. Objective: To perform comprehensive genomic profiling (CGP) to enable the search...
16.
Necchi A, Bratslavsky G, Corona R, Chung J, Millis S, Elvin J, et al.
Eur Urol Focus
. 2018 Jul;
6(1):122-130.
PMID: 30025711
Background: Although both seminomatous and nonseminomatous testicular germ cell tumors (TGCTs) have favorable outcomes with chemotherapy, a subset is chemorefractory, and novel therapeutic options are needed. Objective: To molecularly characterize...
17.
Johnson A, Severson E, Gay L, Vergilio J, Elvin J, Suh J, et al.
Oncologist
. 2017 Sep;
22(12):1478-1490.
PMID: 28912153
Background: Pediatric brain tumors are the leading cause of death for children with cancer in the U.S. Incorporating next-generation sequencing data for both pediatric low-grade (pLGGs) and high-grade gliomas (pHGGs)...